| ALX-350-174-C025 | 25 µg | 163.00 USD | ![]() |
||
| ALX-350-174-C100 | 100 µg | 357.00 USD | ![]() |
||
| Alternative Name: | [Hty2]microcystin-YR |
| Identity: | Identity determined by MS. |
| Formula: | C53H74N10O13 |
| MW: | 1058.5 |
| Purity: | ≥95% (HPLC) |
| Appearance: | White to off-white powder or oily film adhered to inside of the vial. |
| Source/Host: | Isolated from Microcystis aeruginosa. |
| Solubility: | Soluble in methanol or DMSO. |
| Long Term Storage: | -20°C |
| Hazard: | HIGHLY IRRITANT. MAY BE CARCINOGENIC. TOXIC. |
| Handling: | For maximum product recovery after thawing, centrifuge the vial before opening the cap. |
| Background / Technical Information: | Microcystins are a group of cyclic heptapeptide hepatotoxins produced by a number of cyanobacterial genera. The most notable of which, and namesake, is the widespread genus Microcystis. Structurally, all microcystins consist of the generalized structure cyclo(-D-Ala1-X2-D-MeAsp3-Y4-Adda5-D-Glu6-Mdha7-). X and Y are variable L-amino acids, D-MeAsp is D-erythro-ß-methylaspartic acid and Mdha is N-methyldehydroalanine. Adda is the cyanobacteria unique C20 ß-amino acid 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-deca-4,6-dienoic acid. Substitutions of the variable L-amino acids at positions 2 and 4 give rise to at least 21 known primary microcystin analogs and alterations in the other constituent amino acids result in more than 90 reported mycrocystins to date. |


